Go to main content
 
Beat Drugs Fund invites applications for 2022 Funding Exercise of Regular Funding Scheme
****************************************************************************************
The following is issued on behalf of the Secretariat of the Beat Drugs Fund Association (BDFA):
 
     The Beat Drugs Fund (BDF) Regular Funding Scheme (RFS) is inviting applications for the 2022 Funding Exercise from today (July 27) until September 7.
 
     The BDF RFS aims to promote worthwhile anti-drug projects that can help address drug problems. For the 2022 Funding Exercise of the RFS, projects meeting one or more of the priority areas (at Annex) for treatment and rehabilitation, preventive education and publicity, and research will be accorded priority.
 
     The application form and guide for applicants are available on the website of the Narcotics Division (ND) (www.nd.gov.hk/en/beat_drug_fund_2022.html). The deadline for application for the 2022 Funding Exercise of the BDF RFS is 6pm on September 7. For details of guidelines on the submission of applications, please refer to paragraph 7 of the Guide to the 2022 Funding Exercise of the BDF RFS, or pages 39 and 40 of the application form.
 
     The BDFA will also arrange three briefing cum experience sharing sessions online on August 1, August 4 and August 11 for interested applicants. Details can be found on the website of the ND (www.nd.gov.hk/en/beat_briefing_experience_sharing_sessions.html). Representatives of interested organisations may complete the online enrolment form (forms.gle/9cfhsPxLe9VVqhEC7). Participants will be provided with the link and password of the online briefing cum experience sharing sessions via email nearer the time.
 
     Enquiries are welcome by telephone at 2867 2769 or 2867 2286; or via email to bdf@sb.gov.hk.
 
     Results of applications for the 2022 Funding Exercise are expected to be announced in the first quarter of 2023.
 
Ends/Wednesday, July 27, 2022
Issued at HKT 15:14
NNNN
Today's Press Releases  

Attachment

Annex